Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'The Prostate Cancer R' returned 504 results - Page 1 of 26  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology Drug Delivery in Cancer - Technologies, Markets and Companies DNA Repair in Cancer Therapy. Molecular Targets and Clinical...   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom R&D Trends: Prostate Cancer - Newly approved therapies shift treatment dynamics for castrate-resistant disease   Datamonitor, June 2011, Pages: 31 APPENDIX Report methodology R&D Trends: Prostate Cancer - Newly approved therapies shift treatment dynamics for castrate-resistant disease Hormones in Breast and Prostate Cancer   Expert Reviews Ltd, May 2011, Pages: 202 This Special Focus Issue of the peer-reviewed journal Expert Review of Endocrinology and Metabolism brings together experts in the fields of hormone dependent- breast and prostate cancer Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)   Markets and Markets, Nov 2011, Pages: 286 Cancer Drugs Market, By Therapy, 2005 - 2020 ($Thousand) Table 74 Brazil: Prostate Cancer Drugs Market, By Products, 2005 - 2020 ($Thousand) Table 75 Russia: Prostate Cancer Drugs Market, By Therapy, 2005 Drug Delivery in Cancer - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 639 of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples to illustrate different approaches both experimental and clinical A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market   Bioseeker, June 2010, Pages: 838 This report comprises defined and up to date development strategies for 346 prostate cancer drugs within the portfolio of 198 investigators, from Ceased to Marketed. The report extensively analyses Analytical Tool - Prostate Cancer   Bioseeker, Feb 2011 "Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at the same Biomarkers - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 864 as biomarkers in pancreatic cancer miRNA biomarkers of pancreatic cancer Parathyroid cancer biomarkers Proteomic biomarkers of pancreatic cancer Prostate cancer Adipose tissue-derived biomarkers of obesity Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, July 2011, Pages: 2820 This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis   Bioseeker, Sep 2008, Pages: 306 combination breakdown of prostate cancer drugs into R&D approaches - Unique drug-protein target interactome- and protein-protein interactome of drug targets analysis - Pathway profiling of prostate cancer Triple Analysis: Breast Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2410 This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Triple Analysis: Colorectal Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, March 2011, Pages: 2553 This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Prostate Cancer Minimally Invasive Surgery Market in North America and Europe (2011 - 2016)   Transparency Market Research, Nov 2011, Pages: 83 INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) TABLE 25 ANGIODYNAMICS, INC. TOTAL REVENUES AND R&D EXPENSES (USD THOUSAND) TABLE 26 ANGIODYNAMICS, INC. BUSINESS SEGMENT REVENUE (USD Triple Analysis: Pancreatic Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2107 This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Triple Analysis: Breast Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3074 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Colorectal Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3217 This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 2771 This triple analysis focuses on cancer drug development strategies in Lung Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Breast Cancer, Colorectal Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2807 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Triple Analysis: Breast Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, May 2010, Pages: 2361 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2504 This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development   GBI Research, Dec 2011, Pages: 215 ’s Lymphoma Therapeutics Pipeline 6.4.2 Promising Pipeline Molecules 6.5 R&D Pipeline - NSCLC 6.5.1 Promising Pipeline Molecules 6.6 R&D Pipeline - Prostate Cancer 6.6.1 Promising Pipeline Molecules 6.7 R Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network